Abstract
The blood-brain barrier (BBB) has been considered as an important regulator of brain homeostasis, and its disturbance has been implicated in the onset and/or evolution of many pathological manifestations of neurodegenerative and inflammatory diseases [1, 2]. In particular, BBB breakdown has been closely associated with the primary insult, as well as the secondary cell death of stroke. Here, we review the pioneering contributions of leading scientists who have vested interest in advancing our understanding of the pivotal role of BBB in stroke, but also exploiting this knowledge in developing novel BBB-based therapeutic regimens to abrogate stroke symptoms. The study of BBB as a fundamental research theme and as a target for clinical applications in stroke can be approached in three main themes namely, basic science research, translational and clinical research, and emerging therapies for BBB repair in stroke. This minireview captures cutting-edge discoveries establishing BBB as a central target for abetting neuroprotection and neurorestoration in stroke.
Citations
Jul 6, 2014·PloS One·Keith D RochfortPhilip M Cummins
Jan 28, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Yun ZhouGuo-qing Zheng
Feb 11, 2016·Neuropharmacology·Jing WangHong Liao
Oct 27, 2015·Journal of Neurochemistry·Keith D RochfortPhilip M Cummins
Nov 21, 2013·Journal of Neurochemistry·Ying-Na LiKe Jian Liu
Feb 3, 2015·Experimental & Translational Stroke Medicine·Sung-Ha HongLudmila Belayev
Jul 19, 2016·Neurobiology of Disease·Ziyan ZhangHonglian Shi
Jun 25, 2017·Journal of Neuroinflammation·Haiying ZhangYoung-Guen Kwon
Sep 15, 2015·Neuroreport·Gen YanRenhua Wu
Nov 10, 2015·Biochemical Society Transactions·Keith D Rochfort, Philip M Cummins
Sep 4, 2019·Journal of Molecular Neuroscience : MN·Peng GongSheng-Yong Luo
Oct 18, 2019·Brain Circulation·Brooke BonsackKen Arai
Jun 4, 2020·Acta Pharmacologica Sinica·Mu-Bo LiuQi-Hai Gong
Apr 24, 2019·Journal of Clinical Medicine·Sydney ZarrielloCesario V Borlongan
Apr 13, 2017·Journal of Nanobiotechnology·Andrés Da Silva-CandalJosé Castillo
Oct 27, 2016·Immunological Reviews·Ali Alawieh, Stephen Tomlinson
Sep 7, 2018·Experimental and Therapeutic Medicine·Fangbin ChenZhiyong Cao
Jun 6, 2020·Cellular and Molecular Neurobiology·Xiao YangWeiliang Xia
Jan 18, 2020·Scientific Reports·Verónica Viñuela-BerniAndrés Quintanar-Stephano
Jan 28, 2021·International Journal of Molecular Sciences·Ayon BhattacharyaSylvain Doré
Feb 1, 2021·Multiple Sclerosis and Related Disorders·Rheal A TownerRobert C Axtell
May 8, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Jiyao ZhangLuwen Zhu
Jul 15, 2021·The European Journal of Neuroscience·Reai ShanZhihua Huang
Aug 14, 2021·Acta Pharmaceutica Sinica. B·Chenglong GaoTao Pang